Abnormal monoamine metabolism in cerebrospinal fluid in a case of serotonin syndrome.
Nisijima
K
K
D000328:Adult; D000657:Amoxapine / Q000009:adverse effects; D015306:Biogenic Monoamines / Q000134:cerebrospinal fluid*; D002997:Clomipramine / Q000009:adverse effects; D003863:Depression / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D006801:Humans; D008297:Male; D020230:Serotonin Syndrome / Q000134:cerebrospinal fluid* / Q000139:chemically induced; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects
D000657:Amoxapine; D015306:Biogenic Monoamines; D002997:Clomipramine; D017367:Selective Serotonin Reuptake Inhibitors